Michael Ward, MD, PhD, from the National Institutes of Health, answers our questions about his research that measured minimal clinically important improvement of the Routine Assessment of Patient Index Data...
Though current guidelines recommend antiplatelet therapy for patients with cryptogenic stroke, new research is examining the effect of anticoagulation therapy on patient outcomes. Researcher Hooman Kamel,...
Scott D. Newsome, DO, from Johns Hopkins Medicine, answers our questions about new multiple sclerosis disease-modifying therapies, the challenges associated with prescribing these therapies, and more.
Laura T. Safar, MD, from Brigham and Women's Hospital, answers our questions about the use of psychotropics in patients with multiple sclerosis. Read more about her tips for managing drug-drug...
In this podcast, Bruce Stambler, MD, from the Piedmont Heart Institute, discusses his research on 2 investigational inhaled agents for the-self management...
Diane Lipscombe, PhD, and Christopher Moore, PhD, from Brown University, discuss their bioluminescence project, how it can affect neurological therapies in the future, and how you can be part of their...
Systsje Anne Bergstra, PhD, from Leiden University Medical Center answers our questions about her study that compared DMARD treatment regimens among patients with rheumatoid arthritis who failed initial...
Corrine Voils, MD, from Williams S. Middleton Memorial Veterans Hospital and Wisconsin School of Medicine and Public Health, discusses her latest research paper about the myths of medication adherence.
...
Michael Banks, MD, discusses a recent study that details the inconsistencies of antiviral treatment in children hospitalized with an influenza infection, despite recommendations from the Centers for Disease...
